These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27904076)

  • 1. Amorphous-Amorphous Phase Separation of Freeze-Concentrated Protein and Amino Acid Excipients for Lyophilized Formulations.
    Izutsu KI; Yoshida H; Shibata H; Goda Y
    Chem Pharm Bull (Tokyo); 2016; 64(12):1674-1680. PubMed ID: 27904076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miscibility as a factor for component crystallization in multisolute frozen solutions.
    Izutsu KI; Shibata H; Yoshida H; Goda Y
    J Pharm Sci; 2014 Jul; 103(7):2139-2146. PubMed ID: 24903048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Freeze-concentration separates proteins and polymer excipients into different amorphous phases.
    Izutsu K; Kojima S
    Pharm Res; 2000 Oct; 17(10):1316-22. PubMed ID: 11145240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of heat treatment on the physical properties of noncrystalline multisolute systems concentrated in frozen aqueous solutions.
    Izutsu K; Yomota C; Kawanishi T
    J Pharm Sci; 2011 Dec; 100(12):5244-53. PubMed ID: 21780120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of polymer size and cosolutes on phase separation of poly(vinylpyrrolidone) (PVP) and dextran in frozen solutions.
    Izutsu K; Aoyagi N; Kojima S
    J Pharm Sci; 2005 Apr; 94(4):709-17. PubMed ID: 15682383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of co-solutes and process variables on crystallinity and the crystal form of freeze-dried myo-inositol.
    Izutsu KI; Kusano R; Arai R; Yoshida H; Ito M; Shibata H; Sugano K; Goda Y; Terada K
    Int J Pharm; 2016 Jul; 509(1-2):368-374. PubMed ID: 27282535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of counterions on the physical properties of l-arginine in frozen solutions and freeze-dried solids.
    Izutsu K; Fujimaki Y; Kuwabara A; Aoyagi N
    Int J Pharm; 2005 Sep; 301(1-2):161-9. PubMed ID: 16026945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of heat treatment on miscibility of proteins and disaccharides in frozen solutions.
    Izutsu K; Yomota C; Okuda H; Kawanishi T; Randolph TW; Carpenter JF
    Eur J Pharm Biopharm; 2013 Oct; 85(2):177-83. PubMed ID: 23692695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cations and anions on glass transition temperatures in excipient solutions.
    Nesarikar VV; Nassar MN
    Pharm Dev Technol; 2007; 12(3):259-64. PubMed ID: 17613889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Component crystallization and physical collapse during freeze-drying of L-arginine-citric acid mixtures.
    Yamaki T; Ohdate R; Nakadai E; Yoshihashi Y; Yonemochi E; Terada K; Moriyama H; Izutsu K; Yomota C; Okuda H; Kawanishi T
    Chem Pharm Bull (Tokyo); 2012; 60(9):1176-81. PubMed ID: 22976327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of solute miscibility on the micro- and macroscopic structural integrity of freeze-dried solids.
    Izutsu K; Fujii K; Katori C; Yomota C; Kawanishi T; Yoshihashi Y; Yonemochi E; Terada K
    J Pharm Sci; 2010 Nov; 99(11):4710-9. PubMed ID: 20845467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical characterization of meso-erythritol as a crystalline bulking agent for freeze-dried formulations.
    Fujii K; Izutsu K; Kume M; Yoshino T; Yoshihashi Y; Sugano K; Terada K
    Chem Pharm Bull (Tokyo); 2015; 63(5):311-7. PubMed ID: 25948324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freeze-drying of proteins in glass solids formed by basic amino acids and dicarboxylic acids.
    Izutsu K; Kadoya S; Yomota C; Kawanishi T; Yonemochi E; Terada K
    Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):43-8. PubMed ID: 19122314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method development and analysis of the water content of the maximally freeze concentrated solution suitable for protein lyophilisation.
    Seifert I; Bregolin A; Fissore D; Friess W
    Eur J Pharm Biopharm; 2020 Aug; 153():36-42. PubMed ID: 32526356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze-drying of proteins with glass-forming oligosaccharide-derived sugar alcohols.
    Kadoya S; Fujii K; Izutsu K; Yonemochi E; Terada K; Yomota C; Kawanishi T
    Int J Pharm; 2010 Apr; 389(1-2):107-13. PubMed ID: 20097277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes.
    Her LM; Deras M; Nail SL
    Pharm Res; 1995 May; 12(5):768-72. PubMed ID: 7479566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate.
    Lueckel B; Bodmer D; Helk B; Leuenberger H
    Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical Characterization of Vial Strain During Freezing and Thawing Operations Using Amorphous Excipients.
    Strongrich A; Flynn I; Bhatnagar B; Shalaev E; Tchessalov S
    J Pharm Sci; 2024 Sep; 113(9):2699-2707. PubMed ID: 38825234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glass-state amorphous salt solids formed by freeze-drying of amines and hydroxy carboxylic acids: effect of hydrogen-bonding and electrostatic interactions.
    Kadoya S; Izutsu K; Yonemochi E; Terada K; Yomota C; Kawanishi T
    Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):821-6. PubMed ID: 18520087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sodium tetraborate and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids.
    Izutsu K; Ocheda SO; Aoyagi N; Kojima S
    Int J Pharm; 2004 Apr; 273(1-2):85-93. PubMed ID: 15010133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.